Statins considered safe for children with hereditary high cholesterol levels

Statins considered safe for children with hereditary high cholesterol levels

January 18 2018 A new study has found no statin-related safety issues for statins being used to...

Drug Safety Update includes eluxadoline, fingolimod

Drug Safety Update includes eluxadoline, fingolimod

December 19 2017 The MHRA’s latest Drug Safety Update includes information about two black...

Hormonal contraceptives do increase chances of breast cancer, but risk is ‘small’

Hormonal contraceptives do increase chances of breast cancer, but risk is ‘small’

December 13 2017 Women using hormonal contraceptives are exposed to a 20% increased risk of...

MHRA issues new batch of Drug Safety Update notices

MHRA issues new batch of Drug Safety Update notices

November 28 2017 The medicines regulator has issued four Drug Safety Updates relating to...

Vitamin D intake guidance for pregnant mums and babies updated in Scotland

Vitamin D intake guidance for pregnant mums and babies updated in Scotland

November 27 2017 NHS Scotland has updated its recommendations around vitamin D intake for new...

  • Statins considered safe for children with hereditary high cholesterol levels

    Statins considered safe for children with hereditary high cholesterol levels

    Thursday, 18 January 2018 11:07
  • Drug Safety Update includes eluxadoline, fingolimod

    Drug Safety Update includes eluxadoline, fingolimod

    Tuesday, 19 December 2017 10:16
  • Hormonal contraceptives do increase chances of breast cancer, but risk is ‘small’

    Hormonal contraceptives do increase chances of breast cancer, but risk is ‘small’

    Wednesday, 13 December 2017 12:33
  • MHRA issues new batch of Drug Safety Update notices

    MHRA issues new batch of Drug Safety Update notices

    Tuesday, 28 November 2017 09:52
  • Vitamin D intake guidance for pregnant mums and babies updated in Scotland

    Vitamin D intake guidance for pregnant mums and babies updated in Scotland

    Monday, 27 November 2017 14:50

a vaccination syringes image cbSeptember 6 2017

Provisional figures for vaccine effectiveness in the 2016-17 flu season have indicated a poor outcome for older people. 

 Data released by Public Health England showed an adjusted all age vaccine effectiveness (VE) of 39.8% against influenza-laboratory-confirmed primary care consultations for influenza. However, “effectiveness was 40.6% in 18-64 year olds, with no significant effectiveness in ≥65 year olds. VE was 57% for A(H3N2) for 2-17 year olds receiving quadrivalent live attenuated influenza vaccine and 78.6% for influenza B.”

Results for the flu vaccine nasal spray indicate that it reduced the risk of vaccinated children getting flu by 65.8% in across the UK

PHE said: “The flu strain and the flu vaccine, recommended by the World Health Organization, changes every year and the flu vaccine generally provides an important level of protection.

“This year we did not find that the vaccine was significantly effective in protecting against influenza for the over-65 population. This highlights the importance of the vaccine programme in children, which is intended to indirectly protect other vulnerable members of the community, as well as the children themselves.”

The lower effectiveness in the older population for the 2016-17 season “highlights the need to continue to expand the programme among the young, as by protecting them, we can also protect those at risk of severe disease.

“The childhood flu vaccine programme is being expanded to include children in school year 4 in 2017 to 2018. Also, 4 year olds, who were previously offered flu vaccination in general practice, will now be offered it at school in reception class. So all children from reception class through to year 4 will be offered flu vaccination in the forthcoming season.”

Link:
PHE announcement       
PHE ‘Research and analysis: Influenza vaccine effectiveness: 2016 to 2017 estimates’          

Clinical News

January 22 2018 An updated respiratory health plan for Wales has been published, taking forward the national strategy for the next three years.